Atticus Management LLC

This profile gathers the share dealings of Atticus Management LLC across 2 companies, led by Atherogenics Inc and Price Communications Corp. Over a trading history stretching from 30 January 2006 to 28 November 2007, the count stands at 11 filings.

In open-market terms, that means 3 purchases worth €8.4M on one side and 8 sales worth €730k on the other. Netting one side against the other leaves €7.7M of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2007 alone, the filings show no purchases and 7 sales.

A typical purchase (the median) is worth €3.2M.

The record was last updated on 29 November 2007 with an open-market sale (€3,122) in Atherogenics Inc. The last purchase on record was published on 1 February 2006, which is 7,570 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.